Theravance Biopharma, Inc. (TBPH)
17.23
+0.45
(+2.68%)
USD |
NASDAQ |
Apr 17, 16:00
16.95
-0.28
(-1.63%)
After-Hours: 05:21
Theravance Biopharma SG&A Expense (Quarterly) : 20.96M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Integer Holdings Corp. | 57.21M |
| QuidelOrtho Corp. | 194.40M |
| Catalyst Pharmaceuticals, Inc. | 48.23M |
| Relmada Therapeutics, Inc. | 12.26M |
| Avalo Therapeutics, Inc. | 6.534M |